Literature DB >> 10398099

In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.

P Rochaix1, S Krajewski, J C Reed, F Bonnet, J J Voigt, P Brousset.   

Abstract

The expression of the pro-apoptotic proteins (Bax, Bak) and anti-apoptotic proteins (Bcl-2, Bcl-X, Mcl-1) was studied by immunohistochemistry in 110 invasive ductal breast carcinomas. The results were correlated with tumour grade, expression of oestrogen receptor (ER) and p53 protein, and the apoptotic index by combined morphology, immunohistochemistry, and a terminal UTP nick end labelling (TUNEL) procedure. Overall, Bcl-2, Bcl-X, Mcl-1, Bax, Bak, ER, and p53 were detected in 62, 75, 68, 75, 60, 68 and 26 per cent of the cases respectively, but at different levels in each case. A high apoptotic index was correlated with high tumour grade (p<0.001), overexpression of p53 (p<0.001), Bak expression (p<0.001), and low expression of Bcl-2 (p<0.001) and ER (p<0.001). No correlation was found between the apoptotic index and Bax, Bcl-X, and Mcl-1 immunostaining results. The expression of Bcl-2 and Bcl-X was correlated to that of ER. Overall, the results of this study strongly suggest that Bcl-2 and Bak expression is critical in regulating apoptosis in breast carcinomas. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398099     DOI: 10.1002/(SICI)1096-9896(199903)187:4<410::AID-PATH266>3.0.CO;2-F

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

1.  The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.

Authors:  Tamilla Nechiporuk; Stephen E Kurtz; Olga Nikolova; Tingting Liu; Courtney L Jones; Angelo D'Alessandro; Rachel Culp-Hill; Amanda d'Almeida; Sunil K Joshi; Mara Rosenberg; Cristina E Tognon; Alexey V Danilov; Brian J Druker; Bill H Chang; Shannon K McWeeney; Jeffrey W Tyner
Journal:  Cancer Discov       Date:  2019-05-02       Impact factor: 39.397

2.  The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues.

Authors:  Qing Yao; Jianghao Chen; Yonggang Lv; Ting Wang; Juliang Zhang; Jing Fan; Ling Wang
Journal:  Tumour Biol       Date:  2011-08-23

3.  ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy.

Authors:  Luiza Kanczuga-Koda; Mariusz Koda; Jakub Tomaszewski; Katarzyna Jarzabek; Joanna Lotowska; Marek Baltaziak; Urszula Sulkowska; Maria Sobaniec-Lotowska; Stanisław Sulkowski
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

4.  Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells.

Authors:  Carmen Ruiz-Ruiz; Abelardo López-Rivas
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

5.  Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.

Authors:  S Rehman ; J Crow ; P A Revell
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

6.  Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.

Authors:  Emma J Dean; Jeff Cummings; Anne Roulston; Mark Berger; Malcolm Ranson; Fiona Blackhall; Caroline Dive
Journal:  Neoplasia       Date:  2011-04       Impact factor: 5.715

7.  Relationship of p53, Bcl-2, Ki-67 index and E-cadherin expression in early invasive breast cancers with comedonecrosis as an accelerated apoptosis.

Authors:  N Hosaka; T Ryu; W Cui; Q Li; A Nishida; T Miyake; T Takaki; M Inaba; S Ikehara
Journal:  J Clin Pathol       Date:  2006-02-10       Impact factor: 3.411

8.  A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.

Authors:  Haley E Ramsey; Melissa A Fischer; Taekyu Lee; Agnieszka E Gorska; Maria Pia Arrate; Londa Fuller; Kelli L Boyd; Stephen A Strickland; John Sensintaffar; Leah J Hogdal; Gregory D Ayers; Edward T Olejniczak; Stephen W Fesik; Michael R Savona
Journal:  Cancer Discov       Date:  2018-09-05       Impact factor: 39.397

9.  A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy.

Authors:  W J Placzek; J Wei; S Kitada; D Zhai; J C Reed; M Pellecchia
Journal:  Cell Death Dis       Date:  2010-05-06       Impact factor: 8.469

Review 10.  Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy.

Authors:  J Gómez-Navarro; W Arafat; J Xiang
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.